Omicron: What will change in Phase 2 of response?

Omicron: What will change in Phase 2 of response?

1 News - 13 Feb 2022
New Zealand could shift to Phase 2 of its Omicron response soon, after a big jump in Covid-19 community cases at the weekend. People line up in their cars ...

An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial

Nature.com - 18 Apr 2024
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial ...

Efficacy and safety of Link Natural Sudarshana, an Ayurvedic herbal preparation in COVID-19 patients: A phase II ...

ScienceDirect.com - 06 Apr 2024
Efficacy and safety of Link Natural Sudarshana, an Ayurvedic herbal preparation in COVID-19 patients: A phase II ... ...

CureVac announces positive Phase II Covid-19 vaccine trial data

Clinical Trials Arena - 09 Jan 2024
CureVac announces positive Phase II Covid-19 vaccine trial data ...

Increased Healthcare-Associated Infections: The COVID-19 Impact on Hospital Infection Prevention

Contagionlive.com - 22 Apr 2024
Increased Healthcare-Associated Infections: The COVID-19 Impact on Hospital Infection Prevention ...

NIH opens long COVID trials to evaluate treatments for autonomic nervous system dysfunction

National Institutes of Health (NIH) (.gov) - 12 Mar 2024
NIH opens long COVID trials to evaluate treatments for autonomic nervous system dysfunction ...

NIH launches phase 2 long-COVID treatment trials

University of Minnesota Twin Cities - 31 Jul 2023
NIH launches phase 2 long-COVID treatment trials ...

Phase II study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19

BioTechniques - 19 Jul 2023
Phase II study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19 ...

CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration ...

Yahoo Finance - 05 Jan 2024
CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration ... ...

Novel COVID-19 Antiviral Ensitrelvir Provides Earlier Symptom Relief in Phase 3 Trial

Infectious Disease Advisor - 15 Mar 2024
Novel COVID-19 Antiviral Ensitrelvir Provides Earlier Symptom Relief in Phase 3 Trial ...

Africa CDC and Mastercard Foundation launch phase 2 of the Saving Lives and Livelihoods (SLL) initiative to ...

africacdc.org - 29 Nov 2023
Africa CDC and Mastercard Foundation launch phase 2 of the Saving Lives and Livelihoods (SLL) initiative to ... ...

Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study | Scientific Reports

Nature.com - 29 Jan 2024
Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study | Scientific Reports ...

NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment

National Institutes of Health (NIH) (.gov) - 31 Jul 2023
NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment ...

Senhwa doses first subject in Phase II Covid-19 drug trial in Taiwan

Clinical Trials Arena - 10 Nov 2023
Senhwa doses first subject in Phase II Covid-19 drug trial in Taiwan ...

Approximately 17 Million American Adults Have Long COVID Right Now

Contagionlive.com - 11 Apr 2024
Approximately 17 Million American Adults Have Long COVID Right Now ...

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature.com - 28 Aug 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial ...

Shionogi reports data from Phase III portion of Covid-19 drug trial

Clinical Trials Arena - 12 Feb 2024
Shionogi reports data from Phase III portion of Covid-19 drug trial ...

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19 | Scientific Reports

Nature.com - 23 Aug 2023
A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19 | Scientific Reports ...

AIM ImmunoTech concludes dosing in Phase II post-Covid drug trial

Clinical Trials Arena - 22 Nov 2023
AIM ImmunoTech concludes dosing in Phase II post-Covid drug trial ...

Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin ...

Nature.com - 18 Aug 2023
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin ... ...

Phase 2 Covid